Sign in
4

Changes in Ownership

Altimmune, Inc. Filed Acc 0001104659-24-009540

Chief Medical Officer gave up 2,709 shares (to pay taxes)

  • Chief Medical Officer acquired 3,257 shares (grant or award)
  • Chief Medical Officer acquired 9,275 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Harris Matthew Scott Chief Medical Officer 2024-01-30 Option exercise +9,275 43,277 D: show line 1 in the form
Harris Matthew Scott Chief Medical Officer 2024-01-30 Shares withheld for taxes −2,709 $9.80 $26,548 40,568 D: show line 2 in the form
Harris Matthew Scott Chief Medical Officer 2024-01-31 Grant or award +3,257 $2.69 $8,761 43,825 D: show line 3 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Harris Matthew Scott Chief Medical Officer 2024-01-30 Option exercise · Restricted Stock Units −9,275 27,825 D: show line 4 in the form
Loading xslF345X05/tm244961-3_4seq1.xml…